Literature DB >> 15860350

A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma.

Jon C Strefford1, Irina Stasevich, Tim M Lane, Yong-Jie Lu, Tim Oliver, Bryan D Young.   

Abstract

Here we report the complex pattern of genomic imbalances and rearrangements in a panel of 19 renal cell carcinoma cell lines detected with molecular cytogenetic analysis. Consistent heterogeneity in chromosome number was found, and most cell lines showed a near-triploid chromosome complement. Several cell lines showed deletions of the TP53 (alias p53), CDKN2A (alias p16), and VHL genes. Multiplex fluorescence in situ hybridization (M-FISH) analysis revealed chromosome 3 translocated to several other partners chromosomes, as well as breakage events commonly affecting chromosomes 1, 5, 8, 10, and 17. The most common abnormality detected with comparative genomic hybridization (CGH) was deletions of chromosome 3p, with loss of the RASSF1, FHIT, and p44S10 loci frequently involved. CGH gain of 5q showed overrepresentation of the EGR1 and CSF1R genes. Recurrent alterations to chromosome 7 included rearrangement of 7q11 and gains of the EGFR, TIF1, and RFC2 genes. Several lines exhibited rearrangement of 12q11 approximately q14 and overrepresentation of CDK4 and SAS loci. M-FISH revealed several other recurrent translocations, and CGH findings included loss of 9p, 14q, and 18q and gain of 8q, 12, and 20. Further genomic microarray changes included loss of MTAP, IGH@, HTR1B, and SMAD4 (previously MADH4) and gains of MYC and TOP1. An excellent correlation was observed between the genomic array and FISH data, demonstrating that this technique is effective and accurate. The aberrations detected here may reflect important pathways in renal cancer pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15860350     DOI: 10.1016/j.cancergencyto.2004.09.020

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  17 in total

1.  Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis.

Authors:  Julien Laffaire; Sibille Everhard; Ahmed Idbaih; Emmanuelle Crinière; Yannick Marie; Aurelien de Reyniès; Renaud Schiappa; Karima Mokhtari; Khê Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Joëlle Thillet; François Ducray
Journal:  Neuro Oncol       Date:  2010-10-05       Impact factor: 12.300

2.  Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma.

Authors:  Reza Nejati; Shuanzeng Wei; Robert G Uzzo; Sahar Poureghbali; Jianming Pei; Jacqueline N Talarchek; Karen Ruth; Essel Dulaimi; Alexander Kutikov; Joseph R Testa; Tahseen Al-Saleem
Journal:  Clin Genitourin Cancer       Date:  2019-09-26       Impact factor: 2.872

3.  Prognostic significance of TRIM24/TIF-1α gene expression in breast cancer.

Authors:  Monique Chambon; Béatrice Orsetti; Marie-Laurence Berthe; Caroline Bascoul-Mollevi; Carmen Rodriguez; Vanessa Duong; Michel Gleizes; Sandrine Thénot; Frédéric Bibeau; Charles Theillet; Vincent Cavaillès
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

4.  Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.

Authors:  Marieta I Toma; Marianne Grosser; Alexander Herr; Daniela E Aust; Axel Meye; Christian Hoefling; Susanne Fuessel; Daniela Wuttig; Manfred P Wirth; Gustavo B Baretton
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

5.  Relationship between vascular endothelial growth factor and nuclear factor-kappaB in renal cell tumors.

Authors:  Gordana Djordjević; Koviljka Matusan-Ilijas; Emina Sinozić; Giuseppe Damante; Dora Fabbro; Blazenka Grahovac; Ksenija Lucin; Nives Jonjić
Journal:  Croat Med J       Date:  2008-10       Impact factor: 1.351

6.  MAML1 acts cooperatively with EGR1 to activate EGR1-regulated promoters: implications for nephrogenesis and the development of renal cancer.

Authors:  Magnus L Hansson; Stefanie Behmer; Rebecca Ceder; Sadollah Mohammadi; Giulio Preta; Roland C Grafström; Bengt Fadeel; Annika E Wallberg
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

7.  Integrative detection and analysis of structural variation in cancer genomes.

Authors:  Jesse R Dixon; Jie Xu; Vishnu Dileep; Ye Zhan; Fan Song; Victoria T Le; Galip Gürkan Yardımcı; Abhijit Chakraborty; Darrin V Bann; Yanli Wang; Royden Clark; Lijun Zhang; Hongbo Yang; Tingting Liu; Sriranga Iyyanki; Lin An; Christopher Pool; Takayo Sasaki; Juan Carlos Rivera-Mulia; Hakan Ozadam; Bryan R Lajoie; Rajinder Kaul; Michael Buckley; Kristen Lee; Morgan Diegel; Dubravka Pezic; Christina Ernst; Suzana Hadjur; Duncan T Odom; John A Stamatoyannopoulos; James R Broach; Ross C Hardison; Ferhat Ay; William Stafford Noble; Job Dekker; David M Gilbert; Feng Yue
Journal:  Nat Genet       Date:  2018-09-10       Impact factor: 38.330

8.  Gene expression profiling of the synergy of 5-aza-2'-deoxycytidine and paclitaxel against renal cell carcinoma.

Authors:  Tiandong Han; Donghao Shang; Xiuhong Xu; Ye Tian
Journal:  World J Surg Oncol       Date:  2012-09-06       Impact factor: 2.754

9.  Hypoxia inducible factor-1alpha correlates with vascular endothelial growth factor A and C indicating worse prognosis in clear cell renal cell carcinoma.

Authors:  Gordana Dorević; Koviljka Matusan-Ilijas; Emina Babarović; Ita Hadzisejdić; Maja Grahovac; Blazenka Grahovac; Nives Jonjić
Journal:  J Exp Clin Cancer Res       Date:  2009-03-20

10.  The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer.

Authors:  Achim Weber; Ilka Kristiansen; Manfred Johannsen; Beibei Oelrich; Katharina Scholmann; Sven Gunia; Matthias May; Hellmuth-Alexander Meyer; Silvia Behnke; Holger Moch; Glen Kristiansen
Journal:  BMC Cancer       Date:  2008-12-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.